CIBC Bancorp USA’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$184M Sell
437,527
-92,086
-17% -$36.7M 0.23% 106
2026
Q2
$192M Sell
529,613
-15,848
-3% -$5.42M 0.23% 102
2026
Q1
$192M Buy
+545,461
New +$194M 0.26% 98
2025
Q3
$26.5M Buy
+93,962
New +$27.3M 0.15% 108

Other funds holding AMGN

CIBC Bancorp USA's AMGN Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Amgen (AMGN) stake by 17% in Q3 2026, selling an estimated $36.7M and leaving 437,527 shares worth $184M. The position accounts for 0.23% of the portfolio, ranked #106.

CIBC Bancorp USA first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $192M in Q1 2026. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • CIBC Bancorp USA held 437,527 shares of Amgen worth $184M as of Q3 2026.
  • CIBC Bancorp USA sold 92,086 Amgen shares in Q3 2026, an estimated $36.7M.
  • Amgen made up 0.23% of CIBC Bancorp USA's portfolio in Q3 2026, its #106 holding.
  • CIBC Bancorp USA first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Amgen position peaked at $192M in Q1 2026.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.